Astellas Pharma Inc. (YPHA)
Market Closed
26 Jun, 20:00
XFRA 
OTC PINK Primary XFRA €
11. 20
-0.1
-0.885%
€
21.14B Market Cap
- P/E Ratio
0.88% Div Yield
400 Volume
- Eps
€ 11.3
Previous Close Want to track YPHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Astellas Pharma Inc. (YPHA) Statistics
Valuation metrics
Market Cap 21.14B
Enterprise value 1.66B
Trailing P/E (ttm) 13.52
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.01
Price/Book (mrq) 2.16
Enterprise Value/Revenue 0.14
Enterprise Value/EBITDA 0.54
Overview
Shares outstanding 1.79B
Float 1.79B
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 200
Average volume (90 days) 227
Price summary
52-Week low 7.75
52-Week high 14.1
Beta 0.08
50-Day moving average 12.81
200-Day moving average 11.16
Dividends and splits
Forward annual dividend rate 0.43
Forward annual dividend yield 0.0366%
Trailing annual dividend rate 0.44
Trailing annual dividend yield 0.0371%
5-Year annual dividend yield 3.62%
Payout ratio 0.23
Dividend Date 3 Jun 2026
Ex-Dividend Date 31 Mar 2026
Last split factor 125:100
Last split Date 2 Apr 2014
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.14%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.17%
Income Statement
Revenue (ttm) 11.57B
Revenue per share (ttm) 1,194.37
Quarterly revenue growth (yoy) 0.21%
Gross profit (ttm) 9.36B
EBITDA 247B
Net income to common (ttm) 1.58B
Diluted EPS (ttm) 0.88
Quarterly earnings growth (yoy) -0.04%
Balance Sheet
Total cash (mrq) 1.52B
Total cash per share (mrq) 157.19
Total debt (mrq) 3.06B
Total Debt/Equity (mrq) 30.91
Current ratio (mrq) 1.17%
Book value per share (mrq) 5.51
Cash Flow
Cash flow statement 3.03B
Levered free cash flow (LFCF) 2.1B
